Insights: White Papers, Research Studies, Books - Vantage Partners

Browse by Category

Vantage periodically executes a "State of Pharma Alliance Management" report, based on surveys, ...

Our team enjoyed presenting (here's our presentation) at Cambridge Healthtech Institute’s Strategic ...

Biopharma dealmaking has regained momentum. But closing the deal is only half the battle. ...

A Negotiation Scenario Planning Framework In September, the first 10 products were identified for ...

Over the course of our 25 years in the business, we've realized that when a life sciences company ...

Sometimes pharma companies and their partners need to expand “the whole menu, not just the pie” in ...

Experienced leaders who’ve worked across both academia and industry shared their lessons learned ...

Market access negotiations are complex. Depending on the product and competitive context, payers ...

Value-based or pay-for-performance approaches to reimbursement for drugs and devices represent a ...

Originally posted on the Association of Strategic Alliances (ASAP) blog.

As traditional sources of funding dip, universities are scrambling for the cash to support ...

by John Larson and Troy Windt

1 2

The Vantage Partners Insights Center